Mucosal malignant melanomas in head and neck surgery: a retrospective study of six patients and review of the literature

Oral Maxillofac Surg. 2010 Sep;14(3):143-7. doi: 10.1007/s10006-010-0207-z.

Abstract

Introduction: Of all malignant processes of the oral mucosa, 0.5% are malignant melanomas. Because of late diagnosis, pattern of growth, close proximity to the bone (particularly in palatinal localizations), and the correlated infiltration, malignant melanomas have a bad prognosis.

Patients and methods: In this retrospective study, six cases of patients with oral mucosal malignant melanoma are evaluated, and a critical review of the literature is presented. The female to male proportion was 1:1 with an average age of 60.2 years; all patients were treated between January 1999 and July 2007. A neck dissection was performed on two patients because of clinically positive lymph nodes; one patient received interleukin 2 therapy, and three patients received postoperative radiotherapy. Two male patients died.

Conclusions: We recommend biopsy on every growing lesion, pigmented or nonpigmented, for the required diagnosis and, in cases of malignant melanoma, wide excision as a second step. Neck dissections should be performed in patients with clinically positive lymph nodes. Concerning interleukin 2 therapy, further studies should be performed in order to evaluate a routine application.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Fatal Outcome
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin-2 / therapeutic use
  • Male
  • Maxilla
  • Melanoma / secondary
  • Melanoma / surgery*
  • Middle Aged
  • Mouth Neoplasms / surgery*
  • Neck Dissection
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local / pathology
  • Radiotherapy, Adjuvant
  • Retrospective Studies

Substances

  • Antineoplastic Agents
  • Interleukin-2